Sigma Healthcare Limited (ASX:SIG)
Australia · Delayed Price · Currency is AUD 2.620
-0.220 (-7.75%)
Aug 27, 2026, 4:18 PM AEST
Sigma Healthcare Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 10,835 | 6,002 | 3,294 | 3,091 | 2,993 | |
Revenue Growth | 80.53% | 82.18% | 6.59% | 3.27% | 23.67% |
Cost of Revenue | 8,878 | 4,562 | 2,251 | 2,173 | 1,921 |
Gross Profit | 1,957 | 1,440 | 1,043 | 917.7 | 1,072 |
Selling, General & Admin | 964.82 | 717.7 | 490.3 | 488.97 | 497.82 |
Operating Expenses | 964.82 | 717.7 | 490.3 | 488.97 | 497.82 |
Operating Income | 992.05 | 722.59 | 552.65 | 428.73 | 574.54 |
Interest Expense | -114.22 | -91.74 | -64.23 | -53.66 | -39.23 |
Interest & Investment Income | 55.02 | 50.48 | 44.94 | 18.42 | 3.85 |
Earnings From Equity Investments | 37.97 | 30.21 | 23.06 | 13.04 | 8.18 |
Other Non Operating Income (Expenses) | 34.25 | 31.95 | 17.7 | 22.83 | 2.65 |
EBT Excluding Unusual Items | 1,005 | 743.49 | 574.12 | 429.36 | 550 |
Pretax Income | 1,005 | 743.49 | 574.12 | 429.36 | 550 |
Income Tax Expense | 296.42 | 218.04 | 34.46 | 126.9 | 164.99 |
Earnings From Continuing Operations | 708.65 | 525.46 | 539.66 | 302.46 | 385.01 |
Minority Interest in Earnings | 0.53 | 4.46 | 1.36 | 1.87 | 0.92 |
Net Income | 709.18 | 529.91 | 541.01 | 304.33 | 385.93 |
Net Income to Common | 709.18 | 529.91 | 541.01 | 304.33 | 385.93 |
Net Income Growth | 33.83% | -2.05% | 77.77% | -21.14% | - |
Shares Outstanding (Basic) | 11,502 | 10,478 | 9,826 | 1,553 | 1,553 |
Shares Outstanding (Diluted) | 11,510 | 10,485 | 9,826 | 1,553 | 1,553 |
Shares Change | 9.78% | 6.70% | 532.62% | - | 0.13% |
EPS (Basic) | 0.06 | 0.05 | 0.06 | 0.20 | 0.25 |
EPS (Diluted) | 0.06 | 0.05 | 0.06 | 0.20 | 0.25 |
EPS Growth | 21.91% | -8.05% | -71.93% | -21.14% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 517.91 | 546.27 | 240.34 | 432.4 | 271.28 |
Free Cash Flow Per Share | 0.04 | 0.05 | 0.02 | 0.28 | 0.17 |
Dividend Per Share | 0.040 | 0.013 | - | - | - |
Dividend Growth | 207.69% | - | - | - | - |
Gross Margin | 18.06% | 24.00% | 31.66% | 29.69% | 35.83% |
Operating Margin | 9.16% | 12.04% | 16.78% | 13.87% | 19.20% |
Profit Margin | 6.54% | 8.83% | 16.42% | 9.85% | 12.90% |
Free Cash Flow Margin | 4.78% | 9.10% | 7.29% | 13.99% | 9.06% |
EBITDA | 1,038 | 751.37 | 569.05 | 439.94 | 585.76 |
EBITDA Margin | 9.58% | 12.52% | 17.27% | 14.23% | 19.57% |
D&A For EBITDA | 45.82 | 28.79 | 16.4 | 11.21 | 11.22 |
EBIT | 992.05 | 722.59 | 552.65 | 428.73 | 574.54 |
EBIT Margin | 9.16% | 12.04% | 16.78% | 13.87% | 19.20% |
Effective Tax Rate | 29.49% | 29.33% | 6.00% | 29.55% | 30.00% |